{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:54:58Z","timestamp":1787014498691,"version":"build-2736575974"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T00:00:00Z","timestamp":1225152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background<\/jats:bold>\n                    Anaphylaxis is a life\u2010threatening syndrome resulting from the sudden release of mast cell\u2010 and basophil\u2010derived mediators into the circulation. However, pathological evidence of the association between inflammatory mediators and human anaphylaxis is insufficient.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective<\/jats:bold>\n                    The aim of this study was to better understand the relationship between\n                    <jats:italic>in vivo<\/jats:italic>\n                    production of inflammatory mediators and the pathogenesis of anaphylaxis. We also sought to evaluate mast cell activation in anaphylaxis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods<\/jats:bold>\n                    We measured the concentrations of various inflammatory mediators in urine samples, which were collected from 32 anaphylactic patients during the onset of anaphlaxis and during clinical remission, 21 patients with asthma on acute exacerbation and 15 healthy control subjects. Blood and urine specimens were collected from the patients after provocation test. Urinary leukotriene E4 (LTE4), 9\u03b1, 11\u03b2\u2010prostaglandin F2 (9\u03b1, 11\u03b2\u2010PGF2), eosinophil\u2010derived neurotoxin (EDN) and leukotriene B4 glucuronide (LTBG) concentrations were determined by enzyme immunoassay, and the activity of plasma platelet\u2010activating factor acetylhydrolase and serum tryptase concentration were measured using commercially available kits.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    Significantly higher concentrations of urinary LTE4 and 9\u03b1, 11\u03b2\u2010PGF2, which immediately decreased during clinical remission, were observed in the anaphylactic patients than in asthmatic patients on acute exacerbation and healthy control subjects. Concentrations of EDN and LTBG were not significantly different among the anaphylactic patients, asthmatic patients on acute exacerbation and healthy subjects. There was a significant correlation between urinary LTE4 and 9\u03b1, 11\u03b2\u2010PGF2 concentrations in the anaphylactic patients (\n                    <jats:italic>r<\/jats:italic>\n                    =0.672,\n                    <jats:italic>P<\/jats:italic>\n                    =0.005,\n                    <jats:italic>n<\/jats:italic>\n                    =32). In addition, LTE4 concentration in patients with anaphylactic shock is significantly elevated compared with that in patients without anaphylactic shock.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions<\/jats:bold>\n                    This is a report on the significant increase in urinary LTE4 and 9\u03b1, 11\u03b2\u2010PGF2 concentrations during anaphylaxis. Urinary LTE4 and 9\u03b1, 11\u03b2\u2010PGF2 concentrations may be a reliable marker of endogenous production of inflammatory mediators associated with anaphylaxis.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2222.2008.03104.x","type":"journal-article","created":{"date-parts":[[2009,1,6]],"date-time":"2009-01-06T13:39:49Z","timestamp":1231249189000},"page":"72-80","source":"Crossref","is-referenced-by-count":103,"title":["Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis"],"prefix":"10.1111","volume":"39","author":[{"given":"E.","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Mita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Fukutomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,6]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"483","article-title":"The diagnosis and management of anaphylaxis","volume":"115","author":"Lieberman P","year":"2005","journal-title":"an updated practice parameter"},{"key":"e_1_2_6_3_2","first-page":"S2","article-title":"Risk assessment in anaphylaxis","volume":"120","author":"Simons FE","year":"2007","journal-title":"current and future approaches"},{"key":"e_1_2_6_4_2","first-page":"341","article-title":"Anaphylaxis","volume":"110","author":"Kemp SF","year":"2002","journal-title":"a review of causes and mechanisms"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.24"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1201\/b13993-12"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.09.027"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.55.2.183"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.1387"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1998.00368.x"},{"key":"e_1_2_6_11_2","first-page":"1","article-title":"On the role of PGD2 metabolites as markers of mast cell activation in asthma","volume":"644","author":"O'Sullivan S.","year":"1999","journal-title":"Acta Physiol Scand Suppl"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2000.00092.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000237133"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070030"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.1.225"},{"key":"e_1_2_6_16_2","first-page":"948","article-title":"ATS\/ERS Task Force","volume":"26","author":"Pelligrino R","year":"2005","journal-title":"standardisation of lung function testing, interpretative strategies for lung function tests"},{"key":"e_1_2_6_17_2","first-page":"461","article-title":"Efficient method for the quantitation of urinary leukotriene E4","volume":"692","author":"Mita H","year":"1997","journal-title":"extraction using an Empore C18 disk cartridge"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2006.09.010"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70167-7"},{"key":"e_1_2_6_20_2","first-page":"1179","article-title":"Urinary eosinophil protein X in children with atopic asthma","volume":"97","author":"Kristjansson S","year":"1996","journal-title":"a useful marker of antiinflammatory treatment"},{"key":"e_1_2_6_21_2","first-page":"124","article-title":"Measurements of leukotrienes in the urine","volume":"52","author":"Kumlin M.","year":"1997","journal-title":"strategies and applications"},{"key":"e_1_2_6_22_2","first-page":"506","article-title":"Anapylaxis","volume":"120","author":"Finkelman FD.","year":"2007","journal-title":"lessons from mouse models"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.5.9906068"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.152.3.7663802"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5284-6_11"},{"key":"e_1_2_6_26_2","first-page":"769","article-title":"In vivo metabolism of a new class of biologically active phospholipids","volume":"29","author":"Blank ML","year":"1981","journal-title":"1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a platelet activating-hypotensive phospholipid"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(79)91163-X"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5574"},{"key":"e_1_2_6_29_2","first-page":"52","article-title":"Severe immediate type hypersensitivity reactions in 105 German adults","volume":"18","author":"Treudler R","year":"2008","journal-title":"when to diagnose anaphylaxis"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2008.03104.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2008.03104.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T10:16:42Z","timestamp":1697365002000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2008.03104.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1365-2222.2008.03104.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2008.03104.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}